These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 32621886

  • 1. Interleukin-9 Aggravates Isoproterenol-Induced Heart Failure by Activating Signal Transducer and Activator of Transcription 3 Signalling.
    Yang Y, Xu C, Tang S, Xia Z.
    Can J Cardiol; 2020 Nov; 36(11):1770-1781. PubMed ID: 32621886
    [Abstract] [Full Text] [Related]

  • 2. Interleukin(IL)-37 attenuates isoproterenol (ISO)-induced cardiac hypertrophy by suppressing JAK2/STAT3-signaling associated inflammation and oxidative stress.
    Guo X, Wang P, Wei H, Yan J, Zhang D, Qian Y, Guo B.
    Int Immunopharmacol; 2024 Dec 05; 142(Pt B):113134. PubMed ID: 39293311
    [Abstract] [Full Text] [Related]

  • 3. Interleukin-6 family of cytokines mediates isoproterenol-induced delayed STAT3 activation in mouse heart.
    Yin F, Li P, Zheng M, Chen L, Xu Q, Chen K, Wang YY, Zhang YY, Han C.
    J Biol Chem; 2003 Jun 06; 278(23):21070-5. PubMed ID: 12665506
    [Abstract] [Full Text] [Related]

  • 4. Interleukin-10 treatment attenuates pressure overload-induced hypertrophic remodeling and improves heart function via signal transducers and activators of transcription 3-dependent inhibition of nuclear factor-κB.
    Verma SK, Krishnamurthy P, Barefield D, Singh N, Gupta R, Lambers E, Thal M, Mackie A, Hoxha E, Ramirez V, Qin G, Sadayappan S, Ghosh AK, Kishore R.
    Circulation; 2012 Jul 24; 126(4):418-29. PubMed ID: 22705886
    [Abstract] [Full Text] [Related]

  • 5. Isoproterenol induces MD2 activation by β-AR-cAMP-PKA-ROS signalling axis in cardiomyocytes and macrophages drives inflammatory heart failure.
    Qian JF, Liang SQ, Wang QY, Xu JC, Luo W, Huang WJ, Wu GJ, Liang G.
    Acta Pharmacol Sin; 2024 Mar 24; 45(3):531-544. PubMed ID: 37919475
    [Abstract] [Full Text] [Related]

  • 6. HIMF (Hypoxia-Induced Mitogenic Factor)-IL (Interleukin)-6 Signaling Mediates Cardiomyocyte-Fibroblast Crosstalk to Promote Cardiac Hypertrophy and Fibrosis.
    Kumar S, Wang G, Zheng N, Cheng W, Ouyang K, Lin H, Liao Y, Liu J.
    Hypertension; 2019 May 24; 73(5):1058-1070. PubMed ID: 30827145
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Simvastatin prevents isoproterenol-induced cardiac hypertrophy through modulation of the JAK/STAT pathway.
    Al-Rasheed NM, Al-Oteibi MM, Al-Manee RZ, Al-Shareef SA, Al-Rasheed NM, Hasan IH, Mohamad RA, Mahmoud AM.
    Drug Des Devel Ther; 2015 May 24; 9():3217-29. PubMed ID: 26150695
    [Abstract] [Full Text] [Related]

  • 9. A novel histone deacetylase inhibitor Se-SAHA attenuates isoproterenol-induced heart failure via antioxidative stress and autophagy inhibition.
    Cheng T, Liu C, Wang Y, Li G, Feng L, Zhang S, Qi B, Cui J, Guo L, Cao L, Wang Y, Qi Z, Yang L.
    Toxicol Appl Pharmacol; 2024 Jun 24; 487():116957. PubMed ID: 38735590
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. CXCR4 Cardiac Specific Knockout Mice Develop a Progressive Cardiomyopathy.
    LaRocca TJ, Altman P, Jarrah AA, Gordon R, Wang E, Hadri L, Burke MW, Haddad GE, Hajjar RJ, Tarzami ST.
    Int J Mol Sci; 2019 May 08; 20(9):. PubMed ID: 31071921
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Interleukin-17 aggravates right ventricular remodeling via activating STAT3 under both normoxia and hypoxia.
    Huang J, Zhang W, Zhang CL, Wang L.
    BMC Cardiovasc Disord; 2021 May 21; 21(1):249. PubMed ID: 34020615
    [Abstract] [Full Text] [Related]

  • 15. Peroxiredoxin-1 ameliorates pressure overload-induced cardiac hypertrophy and fibrosis.
    Tang C, Yin G, Huang C, Wang H, Gao J, Luo J, Zhang Z, Wang J, Hong J, Chai X.
    Biomed Pharmacother; 2020 Sep 21; 129():110357. PubMed ID: 32531679
    [Abstract] [Full Text] [Related]

  • 16. A new regulation of IL-6 production in adult cardiomyocytes by beta-adrenergic and IL-1 beta receptors and induction of cellular hypertrophy by IL-6 trans-signalling.
    Szabo-Fresnais N, Lefebvre F, Germain A, Fischmeister R, Pomérance M.
    Cell Signal; 2010 Jul 21; 22(7):1143-52. PubMed ID: 20227492
    [Abstract] [Full Text] [Related]

  • 17. A gene therapeutic approach to inhibit calcium and integrin binding protein 1 ameliorates maladaptive remodelling in pressure overload.
    Grund A, Szaroszyk M, Döppner JK, Malek Mohammadi M, Kattih B, Korf-Klingebiel M, Gigina A, Scherr M, Kensah G, Jara-Avaca M, Gruh I, Martin U, Wollert KC, Gohla A, Katus HA, Müller OJ, Bauersachs J, Heineke J.
    Cardiovasc Res; 2019 Jan 01; 115(1):71-82. PubMed ID: 29931050
    [Abstract] [Full Text] [Related]

  • 18. Oltipraz attenuates the progression of heart failure in rats through inhibiting oxidative stress and inflammatory response.
    Tang Y, Guo M, Ma XY, Sun WP, Hao MH, Zhu HY.
    Eur Rev Med Pharmacol Sci; 2018 Dec 01; 22(24):8918-8923. PubMed ID: 30575935
    [Abstract] [Full Text] [Related]

  • 19. Protocatechuic aldehyde protects against isoproterenol-induced cardiac hypertrophy via inhibition of the JAK2/STAT3 signaling pathway.
    Fang X, Liu Y, Lu J, Hong H, Yuan J, Zhang Y, Wang P, Liu P, Ye J.
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Dec 01; 391(12):1373-1385. PubMed ID: 30132020
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.